These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31851842)

  • 1. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
    Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic modifications of amino acid-based organogelators for the investigation of structure-property correlations in drug delivery system.
    Hu B; Sun W; Li H; Sui H; Li S
    Int J Pharm; 2018 Aug; 547(1-2):637-647. PubMed ID: 29933060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.
    Li Z; Cao J; Li H; Liu H; Han F; Liu Z; Tong C; Li S
    Drug Deliv; 2016 Oct; 23(8):3168-3178. PubMed ID: 26912188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
    Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
    Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
    Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of organogels as oral controlled release formulations of hydrophilic drugs.
    Iwanaga K; Kawai M; Miyazaki M; Kakemi M
    Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the in vitro and in vivo degradation behavior of amino acid derivative-based organogels.
    Li Z; Cao J; Hu B; Li H; Liu H; Han F; Liu Z; Tong C; Li S
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1732-41. PubMed ID: 27018332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization.
    Yang Y; Xu L; Gao Y; Wang Q; Che X; Li S
    Drug Dev Ind Pharm; 2012 May; 38(5):550-6. PubMed ID: 22420863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of molecular organogel based on folic acid as a potential green drug carrier for oral route.
    Mohamed MBM; Dahabiyeh LA; Sahib MN
    Drug Dev Ind Pharm; 2022 Aug; 48(8):367-373. PubMed ID: 36094171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.
    Wang D; Zhao J; Liu X; Sun F; Zhou Y; Teng L; Li Y
    Eur J Pharm Sci; 2014 Aug; 60():40-8. PubMed ID: 24815944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
    Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the monostearate/monopalmitate ratio on the oral release of active agents from monoacylglycerol organogels.
    Lupi FR; Mancina V; Baldino N; Parisi OI; Scrivano L; Gabriele D
    Food Funct; 2018 Jun; 9(6):3278-3290. PubMed ID: 29789827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of glutamate-based organogels for biodegradable implants: In vitro study and in vivo observation.
    Hu B; Wang W; Wang Y; Yang Y; Xu L; Li S
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():80-90. PubMed ID: 29025677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organogels in drug delivery.
    Murdan S
    Expert Opin Drug Deliv; 2005 May; 2(3):489-505. PubMed ID: 16296770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug permeation through skin is inversely correlated with carrier gel rigidity.
    Nguyen DV; Li F; Li H; Wong BS; Low CY; Liu XY; Kang L
    Mol Pharm; 2015 Feb; 12(2):444-52. PubMed ID: 25495699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Solvent Parameters for Predicting Organogel Formation.
    Hu B; Sun W; Yang B; Li H; Zhou L; Li S
    AAPS PharmSciTech; 2018 Jul; 19(5):2288-2300. PubMed ID: 29845502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.
    Querobino SM; de Faria NC; Vigato AA; da Silva BGM; Machado IP; Costa MS; Costa FN; de Araujo DR; Alberto-Silva C
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1350-1361. PubMed ID: 30889669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
    Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
    Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
    Mohammed AM; Faisal W; Saleh KI; Osman SK
    Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.